Agile Therapeutics reported $46K in Interest Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Adma Biologics ADMA:US USD 7.24K 4.97K
Agile Therapeutics AGRX:US USD 46K 44K
BioMarin Pharmaceutical BMRN:US USD 5M 2.49M
Jazz Pharmaceuticals JAZZ:US USD 3.5M 2.8M
Pacira PCRX:US USD 1.23M 982K
Pain Therapeutics PTIE:US USD 878K 564K
Pfizer PFE:US USD 70M 40M